**Core Concept**
Crigler Najjar syndrome is a rare genetic disorder affecting the metabolism of bilirubin, a byproduct of red blood cell breakdown. It is characterized by a deficiency in the enzyme uridine diphosphate glucuronosyltransferase (UGT1A1), which is crucial for converting bilirubin into a water-soluble form for excretion.

**Why the Correct Answer is Right**
In Crigler Najjar syndrome, the impaired UGT1A1 enzyme leads to an accumulation of unconjugated bilirubin in the blood, causing jaundice. The elevated bilirubin levels are toxic to the brain, resulting in neurological complications. The condition is inherited in an autosomal recessive pattern and is often associated with a complete deficiency of the UGT1A1 enzyme.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not specify the enzyme responsible for the abnormality in Crigler Najjar syndrome.
**Option B:** This option is incorrect as it does not describe the correct metabolic pathway affected in Crigler Najjar syndrome.
**Option C:** This option is incorrect as it does not accurately describe the inheritance pattern of Crigler Najjar syndrome.

**Clinical Pearl / High-Yield Fact**
Crigler Najjar syndrome is a rare but serious condition that highlights the importance of bilirubin metabolism in maintaining normal liver function. It is essential for clinicians to recognize the symptoms of this condition, such as jaundice and neurological complications, to provide timely and effective treatment.

**Correct Answer: A. Deficiency of the enzyme uridine diphosphate glucuronosyltransferase (UGT1A1).**